SureTrader
Home > Boards > US Listed > Biotechs >

Kadmon Holdings (KDMN)

KDMN RSS Feed
Add KDMN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/21/2017 5:15:16 PM - Followers: 5 - Board type: Free - Posts Today: 0

Healthcare-Biotech company developing kinase inhibitors for autoimmune disease, fibrosis and solid tumors.
SureTrader
KDMN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
KDMN News: Amended Statement of Beneficial Ownership (sc 13d/a) 01/16/2018 05:01:07 PM
KDMN News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 01/12/2018 04:12:18 PM
KDMN News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 01/12/2018 04:10:33 PM
KDMN News: Notice of Effectiveness (effect) 01/11/2018 06:02:19 AM
KDMN News: Securities Registration Statement (simplified Form) (s-3) 12/29/2017 04:18:54 PM
PostSubject
#7   KDMN buy 3.56 stocktrademan 06/21/17 05:15:16 PM
#6   Watching T695 04/06/17 09:27:38 PM
#5   Another paper, all theory and in vitro work, mcp4 08/24/16 08:19:42 AM
#4   Preclinical paper for KD025, a ROCK2 inhibitor, for mcp4 08/21/16 01:59:57 AM
#3   Insider buying! Entered today. Good pipeline IMO. vortmaximum 07/28/16 07:09:03 PM
#2   KDMN IPO reduced to 6.3M shares at $12. mcp4 07/26/16 03:11:02 PM
#1   Kadmon shares are expected to price between $16 mcp4 07/26/16 09:17:55 AM
PostSubject